Clinical Studies

Savara is working to initiate a second Phase 3 clinical study of Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP) and expects to speak with the U.S. Food and Drug Administration (FDA) regarding a confirmatory Phase 3 study in non-cystic fibrosis bronchiectasis (NCFB).

A pivotal Phase 3 study, called AVAIL, is ongoing and is evaluating AeroVanc for the treatment of MRSA in people living with cystic fibrosis. A Phase 2a clinical study of Molgradex for the treatment of nontuberculous mycobacterial (NTM) infection in people living with cystic fibrosis, called ENCORE, is also ongoing.

Read more


We are advancing a pipeline of novel inhalation therapies for the treatment of severe pulmonary conditions.

Read more


We focus on rare respiratory diseases in order to give patients with unmet medical needs better treatment options.

Read more

Visit the AeroVanc website to learn more about MRSA in Cystic Fibrosis, AeroVanc and our pivotal Phase 3 AVAIL study

Read more



Visit our PAP portal where patients and doctors can learn more about this disease

Read more

Back to Top
Savara Nasdaq Opening Bell Ceremony - July 23, 2018

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies allow us to count visits and traffic sources, so we can measure and improve the performance of our site.

We track anonymized user information to improve our website.
  • _ga
  • _gid
  • _gat

Google Analytics works by means of tracking code that is added to the pages of our website. Every user is registered with a unique ID, so that Google Analytics can provide us with insight into how many unique visitors there are to the site, for example, and how many users return. With Google Analytics, we can survey how often any single user has visited the website, what pages they visited, for how long they stayed and how they interacted with the site.
  • __utma
  • __utmt
  • __utmb
  • __utmz
  • __utmv

Decline all Services
Accept all Services